Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4986017 | 0.78 | KDM4E (0.39) | KDM4EHPGDTSHRNPSR1LMNA | |
| SCHEMBL4988086 | 0.73 | NPC1 (0.33) | KDM4EHPGDTSHR | |
| SCHEMBL542452 | 0.62 | LMNA (0.36) | KDM4ETSHRNPSR1LMNACYP2C19 | |
| SCHEMBL4954515 | 0.61 | TSHR (0.35) | TSHRNPSR1LMNA | |
| SCHEMBL632188 | 0.61 | LMNA (0.34) | KDM4ETSHRNPSR1LMNACYP2C19 | |
| SCHEMBL11410484 | 0.61 | LMNA (0.34) | KDM4ETSHRNPSR1LMNAPOLB | |
| SCHEMBL5062854 | 0.61 | LMNA (0.34) | KDM4ETSHRNPSR1LMNACYP2C19 | |
| SCHEMBL2981814 | 0.60 | LMNA (0.33) | TSHRNPSR1LMNA | |
| SCHEMBL4952322 | 0.60 | LMNA (0.33) | LMNA | |
| SCHEMBL9190795 | 0.58 | TSHR (0.32) | KDM4ETSHRNPSR1LMNACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035284-B2 | UV-curable glass fiber sizing compositions | OCV INTELLECTUAL CAPITAL, LLC (US) | 2018-07-31 | — | — | US | disclosed |
| US-20160297105-A1 | UV-CURABLE GLASS FIBER SIZING COMPOSITIONS | OWENS CORNING INTELLECTUAL CAPITAL, LLC | 2016-10-13 | — | — | US | disclosed |
| WO-2015084753-A1 | UV-CURABLE GLASS FIBER SIZING COMPOSITIONS | OCV INTERLLECTUAL CAPITAL, LLC (US) | 2015-06-11 | — | — | WO | disclosed |
| US-7361755-B2 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-04-22 | — | — | US | disclosed |
| US-20050085636-A1 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | CIBA SPECIALTY CHEMICALS CORP. | 2005-04-21 | — | — | US | disclosed |
| EP-1178010-B1 | Colorless aqueous ammonium sulfide solution | DU PONT (US) | 2005-03-30 | — | — | EP | disclosed |
| EP-1456173-A1 | TRANSITION-METAL-CATALYZED PROCESS FOR THE CONVERSION OF ALKENES TO STERICALLY HINDERED SUBSTITUTED N-ALKOXYAMINES | Ciba SC Holding AG (CH) | 2004-09-15 | — | — | EP | disclosed |
| US-6664353-B2 | Compounds providing stable free radical-mediated polymerization processes which yield polymers having low polydispersity at enhanced rates of polymerization and enhanced monomer to polymer conversions | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-12-16 | — | — | US | disclosed |
| US-20030149208-A1 | Method of controlling polymer molecular weight and structure | ANDERSON ALBERT G (US) | 2003-08-07 | — | — | US | disclosed |
| US-20030125494-A1 | Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes | NESVADBA PETER (CH) | 2003-07-03 | — | — | US | disclosed |
| WO-2003053931-A1 | TRANSITION-METAL-CATALYZED PROCESS FOR THE CONVERSION OF ALKENES TO STERICALLY HINDERED SUBSTITUTED N-ALKOXYAMINES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-07-03 | — | — | WO | disclosed |
| EP-0951485-B1 | METHOD OF CONTROLLING POLYMER MOLECULAR WEIGHT AND STRUCTURE | DU PONT (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6479608-B1 | Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-11-12 | — | — | US | disclosed |
| US-20020061989-A1 | Method of controlling polymer molecular weight and structure | ANDERSON ALBERT G (US) | 2002-05-23 | — | — | US | disclosed |
| US-20020058772-A1 | Method of controlling polymer molecular weight and structure | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-05-16 | — | — | US | disclosed |
| US-6388004-B1 | AQUEOUS SOLUTION OF AMMONIUM SULFIDE CONTAINING SODIUM THIOCYANATE | E.I. DU PONT DE NEMOURS AND COMPANY | 2002-05-14 | — | — | US | disclosed |
| EP-1178010-A1 | Colorless aqueous ammonium sulfide solution | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-02-06 | — | — | EP | disclosed |
| US-6271340-B1 | LIVING FREE RADICAL POLYMERIZATION INITIATED BY AN ALKOXYAMINE INITIATOR OR NITROXIDE | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-08-07 | — | — | US | disclosed |
| EP-0951485-A2 | METHOD OF CONTROLLING POLYMER MOLECULAR WEIGHT AND STRUCTURE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998030601-A2 | METHOD OF CONTROLLING POLYMER MOLECULAR WEIGHT AND STRUCTURE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149208-A1 | Method of controlling polymer molecular weight and structure | NOS2, NOS1, NOS3 | KDM4E 356/4885HPGD 246/4885TSHR 4801/4885 |
| US-20050085636-A1 | Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines | PNMT, NNMT, TET2 | KDM4E 1018/4885HPGD 2393/4885TSHR 2474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.